Connect with us

Market

CRISPR Therapeutics (NASDAQ:CRSP), Chatham Lodging Trust (NYSE:CLDT) Set to Open Higher In Today’s Session

Published

on

CRISPR Therapeutics (NASDAQ:CRSP) and development partner Vertex Pharmaceuticals (NASDAQ:VRTX) announce that the first beta thalassemia patient has been dosed with CTX001, a gene therapy based on the CRISPR/Cas9 gene editing approach.

The patient is enrolled in a Phase 1/2 study evaluating CTX001 in patients with hemoglobin disorders. The first sickle cell disease subject should be dosed by mid-year.

CRSP is up 11% premarket, stoked by Roche’s bid for Spark Therapeutics.

Wow the future of Autonomous flight is finally here with the launch of ASDN passenger drone Elroy

Chatham Lodging Trust (NYSE:CLDT) jumps 4.1% in premarket trading after Q4 adjusted EBITDA of $28.9M beat consensus estimate of $27.5M.

Results reflected increased demand in the Boston area related to gas explosions in September that displaced many residents and spurred better-than-expected at three of its hotels in the region.

Q4 adjusted EBITDA of $28.9M beats consensus estimate of $27.5M.

Q4 portfolio RevPAR of increased 4.1% for Chatham’s 40, comparable wholly owned hotels; average daily rate improved 1.5% to $162 and occupancy rose 2.4% to 77%.

Q4 comparable hotel EBITDA margins of 36.5%, up 20 basis points.

2019 adjusted FFO per share guidance of $1.78-$1.88 trails consensus estimate of $1.98.

Sees year RevPAR growth of -1.5% to +0.5%; total hotel revenue of $325.5M-$331.5M.

Q1 adjusted FFO per share guidance of 30 cents-33 cents trails consensus of 38 cents; RevPAR growth of 1.5%-0.0%; total hotel revenue of $73.3M-$74.3M.

ASDN could be a potential acquisition target for Uber as it develops its patents and tech for the long awaited Uber Air

Continue Reading

Market

ConforMIS Inc (NASDAQ: CFMS): Premium Members Made A Quick 65% Profit In Just 1 week

Published

on

Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here http://tradersinsights.com/pricing/
JOIN US NOW: For Details Contact us at info@tradersinsights.com

Or You can send me a friend request on facebook here https://www.facebook.com/sebastian.gomestradersinsights

Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-

We told our members in facebook private group to buy ConforMIS Inc (NASDAQ: CFMS) yesterday (march 13th) at $1.36. Now look at the price of the stock – its up 65% at $2.25 from our buy price. This is how easy money they made. If you had invested $5,000 in CFMS, it could had been moved up to $8,250. It’s not yet late, join us at info@tradersinsights.com

Continue Reading

Market

Rockwell Medical Inc (NASDAQ: RMTI): Premium Members Made A Quick 20% Profit In 24 Hours

Published

on

Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here http://tradersinsights.com/pricing/
JOIN US NOW: For Details Contact us at info@tradersinsights.com

Or You can send me a friend request on facebook here https://www.facebook.com/sebastian.gomestradersinsights

Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-

We told our members in facebook private group to buy Rockwell Medical Inc (NASDAQ: RMTI) yesterday (march 18th) at $5.42. Now look at the price of the stock – its up 20% at $6.55 from our buy price. This is how easy money they made. If you had invested $5,000 in RMTI, it could had been moved up to $6,000. It’s not yet late, join us at info@tradersinsights.com

Continue Reading

Market

Sorrento Therapeutics Inc (NASDAQ: SRNE): Members Made A Hefty 15% Profit In 24 Hours

Published

on

By

Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here http://tradersinsights.com/pricing/

 JOIN US NOW: For Details Contact us at info@tradersinsights.com

 Or You can send me a friend request on facebook here https://www.facebook.com/sebastian.gomestradersinsights

Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-

We told our members in facebook private group to buy Sorrento Therapeutics Inc (NASDAQ: SRNE) yesterday (march 18th) at $2.67. Now look at the price of the stock – its up 15% at $3.23 from our buy price. This is how easy money they made. If you had invested $5,000 in SRNE, it could had been moved up to $5,750.  It’s not yet late, join us at info@tradersinsights.com

Continue Reading
Advertisement

Trending